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Differences in cognitive impairment of
relapsing remitting, secondary, and
primary progressive MS
S.C.J. Huijbregts, PhD; N.F. Kalkers, MD, PhD; L.M.J. de Sonneville, PhD; V. de Groot, MD, PhD;
I.E.W. Reuling, MSc; and C.H. Polman, MD, PhD
Abstract—Objective: To investigate the cognitive skills of patients with relapsing remitting multiple sclerosis (RRMS),
secondary progressive MS (SPMS), and primary progressive MS (PPMS) relative to healthy control subjects and to assess
whether there is heterogeneity in the type of cognitive disabilities demonstrated by patients with different MS pheno-
types. Methods: RRMS patients (n  108), SPMS patients (n  71), PPMS patients (n  55), and healthy control subjects
(n  67) underwent neuropsychological assessment with the Brief Repeatable Battery of Neuropsychological Tests.
Results: Relative to controls, cognitive performance of RRMS patients was deficient when tasks required higher-order
working memory (WM) processes (Word List Generation, 10/36 Spatial Recall Test, Symbol Digit Modalities Test). PPMS
and SPMS patients performed poorer than control subjects on all tasks. SPMS patients performed more poorly than PPMS
patients when tasks required higher-order WM processes, except when speed of information processing played a relatively
important role (Symbol Digit Modalities Test, Paced Auditory Serial Addition Test). Whereas RRMS patients generally
performed better than the progressive subtypes, they showed relatively poor verbal fluency. Conclusion: MS patients with
different disease courses have different cognitive profiles.
NEUROLOGY 2004;63:335–339
Cognitive impairment is present in 40 to 60% of pa-
tients with multiple sclerosis (MS)1,2 and occurs in all
MS subtypes.3-6 Previously, secondary progressive
(SP) MS and primary progressive (PP) MS were of-
ten both classified as chronic progressive MS, but
following the increase of reports on differences in
pathology,7-10 this classification was eliminated.11 In
a meta-analysis of effect sizes utilizing the older
classification of MS patients, it was shown that
chronic progressive MS patients were more likely
than relapsing remitting (RR) MS patients to
present with verbal IQ, fluency, and comprehension
deficits, information-processing speed deficits, and
cognitive flexibility and abstraction impairments.12
In comparison with healthy control subjects, RRMS
patients were most likely to present with memory
problems.
In studies distinguishing SPMS, PPMS, and
RRMS, a higher prevalence and greater severity of
cognitive deficits have been reported for SPMS com-
pared with RRMS and PPMS.3,4,7 Only one study
showed qualitative differences between all three MS
subtypes: PPMS and SPMS patients had more diffi-
culties with verbal new learning than RRMS pa-
tients, and SPMS and RRMS patients had more
difficulties with visuospatial new learning (while
controlling for visuospatial perceptual skills) than
PPMS patients.13 Two studies comparing SPMS and
PPMS patients confirmed impaired visuospatial
working memory (WM) in SPMS patients relative to
PPMS patients.3,7 Studies focusing on the type of
cognitive problems observed in RRMS patients
showed impairments when WM load was high or
WM content had to be manipulated5,6 and when ver-
bal fluency was required.14 Unfortunately, MS pa-
tients with progressive phenotypes were not included
in the studies reporting higher-order cognitive pro-
cessing deficits in RRMS,5,6,14 whereas other studies
included only the progressive subtypes.3,7 The cur-
rent study re-evaluates differences in cognitive pro-
file between all three MS subtypes using relatively
large samples for each subtype and compares perfor-
mance with that of healthy control subjects.
Methods. Subjects. Two hundred thirty-four patients with
clinically definite MS15 were recruited from all patients receiving
regular follow-up care at the Vrije Universiteit Medical Center
(VUMC). In addition, 67 control subjects were recruited through
advertisements in hospital and other newspapers. All subjects
gave (written) informed consent to participate in this study, which
was approved by the Ethics Committee of the VUMC. Patients were
classified as RRMS (n  108), SPMS (n  71), or PPMS (n  55).11
Patients had not undergone relapse within 4 weeks of testing.
A full medical history and detailed neurologic examination were
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obtained for all patients before assessment. For control subjects,
medical history was obtained by means of a questionnaire fol-
lowed by an interview preceding assessment. In case these evalu-
ations showed current depression or (a history of) drug or alcohol
abuse, psychiatric disorders other than depression, traumatic
brain injury, metabolic or other CNS disorders with known effects
on memory and concentration, diabetes, cardiovascular illness,
insufficient command of the Dutch language, visual acuity of
6/12, or learning disabilities, subjects did not participate in the
neuropsychological assessment.
Physical disability of the patients was scored using the Ex-
panded Disability Status Scale (EDSS).16 Level of education was
coded as 1) when the participant did not finish secondary educa-
tion or graduated at lower levels, 2) when the participant gradu-
ated from secondary education at intermediate levels or started
postsecondary education but did not finish, or 3) when the partic-
ipant graduated from secondary education at higher levels or fin-
ished postsecondary education. Table 1 shows age, education
level, and gender distribution for all groups as well as EDSS
scores and disease duration for the MS patients.
Neuropsychological tasks. Neuropsychological assessment
was performed with the Brief Repeatable Battery of Neuropsycho-
logical Tests (BRB-N).17 The Bushke Verbal Selective Reminding
Test (SRT) is a measure of verbal learning and delayed recall of a
12-word list. The Long-Term Storage (LTS) score represents the
sum of words recalled on two consecutive trials without remind-
ing. The Consistent Long-Term Retrieval (CLTR) score is the sum
of words recalled on all the subsequent trials without reminding.
The Total Delay score is the number of words recalled after a
delay of 10 minutes.
The 10/36 Spatial Recall Test measures visuospatial learning
and memory. It requires subjects to recall the placement of 10
checkers that are randomly placed on a 6  6 checkerboard. One
score is the sum of correct responses in the three immediate recall
trials (10/36 SRT). The other score is delayed recall after 15 min-
utes (10/36 SRT Delay).
The Symbol Digit Modalities Test (SDMT) examines speed of
information processing and complex visual scanning. The subject
examines a series of nine geometric symbols that are labeled 1 to
9. During 90 seconds, the subject substitutes as many symbols as
possible by the corresponding number and responds verbally. The
score is the number of correct substitutions.
The Paced Auditory Serial Addition Test (PASAT) requires
cognitive abilities such as mental calculation, interference sup-
pression, and information-processing speed. Subjects must be able
to rapidly refresh WM content and resist interference from a pre-
vious response. The subject is instructed to add 60 pairs of digits
such that each number is added to the one that immediately
precedes it and report the outcome verbally. The digits are pre-
sented by tape, first at a rate of every 3 seconds per digit, the
second trial with every 2 seconds per digit. The score is the num-
ber of correct responses per trial (PASAT_3, PASAT_2).
The Word List Generation (WLG) is a semantic verbal fluency
test evaluating the spontaneous production of names of a given
category (animals) within 90 seconds. The score is the number of
correct names. This version of the WLG is a modified version of
the phonemic naming task (e.g., words beginning with F, A, or S)
in the original BRB-N. Cognitive abilities required by WLG in-
clude associative thinking (clustering), mental imagery, and
switching.18
Statistical analysis. Differences between groups on clinical
and demographic characteristics were analyzed by means of
independent-samples Student t-tests (two tailed; age and disease
duration), independent-samples Mann–Whitney U test for ordinal
or rank data (EDSS and level of education), and Pearson 2 tests
(gender distribution).
Pearson correlations (for age and disease duration) and Spear-
man rank order correlations (for EDSS and level of education;
bivariate, two tailed) were calculated to examine the relations
between clinical and demographic characteristics and task perfor-
mance. The relation between task performance and gender was
investigated by means of independent-samples Student t-tests
(two tailed).
Two multivariate procedures (SPSS 11.0; Chicago, IL) with all
BRB-N scores as dependent variables were performed to examine
differences between control subjects and MS patients and differ-
ences between MS subtypes. Age and gender were included as
covariates in both procedures. Contrast analyses were performed
to examine the direction of group differences on different tasks. As
a measure of the effect sizes, the Cohen d was calculated, which
indicates the magnitude of mean differences (using the estimated
marginal means) in SD units. Following Cohen,19 effect sizes can
be interpreted as being small (d  0.2), medium (d  0.5), or large
(d  0.8). Considering the strong correlations of EDSS and disease
duration with each other (r  0.62, p  0.001) and with age
(EDSS: r  0.59, p  0.001; disease duration: r  0.58, p  0.001),
these were not included simultaneously as covariates in the mul-
tivariate procedure comparing performance of the MS groups to
prevent overcorrection. Disease duration and EDSS were entered
separately (in addition to gender) in two multivariate post-hoc
procedures to investigate possible differences as compared with
when age was included.
Results. Control subjects, RRMS patients, and SPMS
patients were younger than PPMS patients. RRMS pa-
tients were also younger than control subjects and SPMS
patients. Gender distribution differed between SPMS pa-
tients, which was the only group with a majority of men,
and the other groups. RRMS patients had lower EDSS
scores and shorter disease duration than PPMS and SPMS
patients, and SPMS patients were less disabled than
Table 1 Demographic and clinical characteristics
Characteristic Controls RRMS SPMS PPMS Significant differences*
n 67 108 71 55
Age (SD), y 44.1 (13.8) 35.5 (8.8) 45.1 (8.2) 53.9 (11.6) 1, 3, 4, 5, 6
Education (SD) 2.16 (0.75) 2.25 (0.59) 2.17 (0.66) 2.27 (0.83)
Gender, F/M, % 63/37 70/30 42/58 60/40 2,† 4, 6‡
EDSS (SD) 2.4 (1.1) 5.0 (1.1) 5.8 (1.6) 4, 5, 6§
Dur (SD) 3.4 (4.1) 12.3 (6.8) 13.0 (8.2) 4, 5
* Student t-test for age and disease duration, Mann–Whitney U test for EDSS and education, Pearson 2 test for gender; p  0.001,
except where noted.
† p  0.016.
‡ p  0.048.
§ p  0.004.
RR  relapsing - remitting; MS  multiple sclerosis; SP  secondary progressive; PP  primary progressive; Education: 1  low, 2 
intermediate, 3  high; EDSS  Expanded Disability Status Scale; Dur  disease duration. Significant differences: 1  controls–
RRMS, 2  controls–SPMS, 3  controls–PPMS, 4  RRMS–SPMS, 5  RRMS–PPMS, 6  SPMS–PPMS.
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PPMS patients. Groups did not differ with respect to mean
level of education (see table 1).
Women performed better than men on the SRT (LTS:
T[299]  5.0, p  0.001; CLTR: T  4.7, p  0.001; Total
Delay: T  4.9, p  0.001), SDMT (T  3.8, p  0.001), and
WLG (T  3.5, p  0.001). Age, disability level, and dis-
ease duration generally correlated negatively and signifi-
cantly with task performance, whereas a higher level of
education was associated with better task performance
(see table E-1 in the supplementary material on the Neu-
rology Web site; go to www.neurology.org). The only excep-
tion was WLG performance, which did not show a
significant association with any of these factors. A more
detailed analysis of the (lack of) an association with age
showed that for control subjects and PPMS patients, a
curvilinear estimation of the relationship (controls: R2 
0.0322; PPMS: R2  0.0921) fitted the data better than a
linear estimation (controls: R2  0.0012; PPMS: R2 
0.0237). To control for a quadratic relation between age
and task performance for WLG, a univariate analysis was
performed in which age * age was introduced as an addi-
tional covariate. For RRMS and SPMS patients, the qua-
dratic and linear fits differed much less (RRMS: R2 
0.1008 vs R2  0.0936; SPMS: R2  0.0065 vs R2 
0.0049). In addition, for RRMS patients, there was a stron-
ger correlation with age (r  0.31, p  0.001). Consider-
ing the apparent differences between groups in the
relation between age and WLG performance, this task was
also analyzed by means of pairwise comparisons
(independent-samples Student t-tests) for different age
categories.
Neuropsychological task performance. Table 2 shows
the adjusted group means for each dependent variable af-
ter controlling for gender and age (unadjusted means [SD]
Table 2 Adjusted group means (SE) and 95% CIs after controlling for age and gender
Test Ctrl, n  67 95% CI RR, n  108 95% CI SP, n  71 95% CI PP, n  55 95% CI
SRT
LTS 50.4 (1.5) 47.7 53.3 48.5 (1.3) 46.0 51.1 45.1 (1.5) 42.1 48.0 44.0 (1.8) 40.5 47.6
CLTR 39.8 (1.7) 36.4 43.2 39.8 (1.5) 36.9 42.8 32.8 (1.7) 29.4 36.2 35.0 (2.1) 30.9 39.2
Total Delay 9.6 (0.2) 9.1 10.1 9.6 (0.2) 9.2 10.0 8.5 (0.2) 8.0 9.0 9.0 (0.3) 8.4 9.5
PASAT
PASAT_2 36.5 (1.7) 33.1 39.8 33.6 (1.5) 30.7 36.4 29.5 (1.7) 26.2 32.8 29.7 (2.0) 25.7 33.7
PASAT_3 46.1 (1.8) 42.5 49.7 44.9 (1.6) 41.8 48.0 40.2 (1.8) 36.6 43.7 38.5 (2.2) 34.1 42.8
SDMT 60.2 (1.6) 57.1 63.3 54.3 (1.3) 51.7 57.0 45.1 (1.6) 42.1 48.2 47.8 (1.9) 44.0 51.6
10/36 Spatial Recall
10/36 SRT 24.0 (0.6) 22.9 25.2 21.4 (0.5) 20.4 22.3 17.7 (0.6) 16.5 18.8 20.5 (0.7) 19.1 21.9
10/36 SRT Delay 8.5 (0.3) 8.0 9.0 7.7 (0.2) 7.2 8.1 6.5 (0.3) 6.0 7.1 7.7 (0.3) 7.0 8.3
WLG 34.6 (0.8) 33.0 36.2 25.7 (0.7) 24.3 27.1 25.1 (0.8) 23.5 26.7 29.3 (1.0) 27.4 31.3
Ctrl  control; RR  relapsing - remitting; SP  secondary progressive; PP  primary progressive; SRT  Selective Reminding Test;
LTS  Long-Term Storage; CLTR  Consistent Long-Term Retrieval; PASAT  Paced Auditory Serial Addition Task (PASAT_2  2
s/digit; PASAT_3  3 s/digit); SDMT  Symbol Digit Modalities Test; 10/36 Spatial Recall (10/36 SRT  Immediate Recall; 10/36 SRT
Delay  Delayed Recall); WLG  Word List Generation.
Table 3 Contrast estimates (CEs) for differences between controls and multiple sclerosis subtypes after controlling for age and gender
Test Ctrl vs RR 95% CI p d Ctrl vs SP 95% CI p d Ctrl vs PP 95% CI p d
SRT
LTS CE  1.8 5.8 2.1 0.358 0.16 CE  5.3 9.5 1.2 0.012 0.41 CE  6.3 10.9 1.7 0.007 0.45
CLTR CE  0.3 4.5 4.6 0.989 0.002 CE  7.0 11.9 2.2 0.005 0.46 CE  4.8 10.1 0.56 0.079 0.29
Total Delay CE  0.002 0.65 0.64 0.996 0.001 CE  1.1 1.8 0.42 0.002 0.53 CE  0.6 1.4 0.14 0.111 0.26
PASAT
PASAT_2 CE  2.9 7.3 1.5 0.200 0.22 CE  6.9 11.6 2.2 0.004 0.47 CE  6.7 11.9 1.6 0.011 0.40
PASAT_3 CE  1.2 6.0 3.6 0.621 0.09 CE  5.9 11.0 0.89 0.021 0.37 CE  7.6 13.2 2.1 0.007 0.42
SDMT CE  5.9 10.0 1.7 0.006 0.46 CE  15.1 19.5 10.7 0.001 1.08 CE  12.4 17.3 7.6 0.001 0.88
10/36 Spatial Recall
10/36 SRT CE  2.7 4.2 1.2 0.001 0.57 CE  6.4 8.0 4.7 0.001 1.35 CE  3.5 5.3 1.7 0.001 0.76
10/36 SRT Delay CE  0.831 1.5 0.13 0.021 0.41 CE  2.0 2.7 1.2 0.001 0.89 CE  0.8 1.7 0.02 0.045 0.42
WLG CE  8.9 11.0 6.7 0.001 1.37 CE  9.5 11.7 7.2 0.001 1.34 CE  5.2 7.7 2.7 0.001 0.72
Ctrl  control; RR  relapsing - remitting; SP  secondary progressive; PP  primary progressive; SRT  Selective Reminding Test; LTS  Long-Term
Storage; CLTR  Consistent Long-Term Retrieval; PASAT  Paced Auditory Serial Addition Task (PASAT_2  2 s/digit; PASAT_3  3 s/digit); SDMT 
Symbol Digit Modalities Test; 10/36 Spatial Recall (10/36 SRT  Immediate Recall; 10/36 SRT Delay  Delayed Recall); WLG  Word List Generation.
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for each group are provided in table E-2 on the Neurology
Web site). The first multivariate analysis showed large
between-group differences (F[27,867]  5.9, p  0.001,
2  0.16). The largest effect sizes were found for SDMT,
10/36 Spatial Recall, and WLG (table 3). RRMS patients
performed poorer than control subjects on these three
tasks. SPMS and PPMS patients performed poorer than
control subjects on all tasks, but the greatest differences
were observed for SDMT, 10/36 Spatial Recall, and WLG
(see Cohen d in table 3). The second multivariate analysis
including only MS patients also showed large between-
group differences (F[18,444]  4.2, p  0.001, 2  0.15).
Effect sizes were smaller but still in the moderate range
(table 4). RRMS patients scored higher than SPMS pa-
tients on all measures except WLG and SRT-LTS. RRMS
performed better than PPMS patients on the PASAT and
SDMT but performed poorer on the WLG. SPMS patients
performed poorer than PPMS patients on two of the five
tasks: 10/36 Spatial Recall and WLG. The largest differ-
ence was observed for WLG (see Cohen d in table 4).
A number of differences between control subjects and
RRMS patients (SDMT, 10/36 SRT Delay), control subjects
and PPMS patients (SRT-CLTR and Total Delay), SPMS
and RRMS patients (SRT-LTS and WLG), and PPMS and
RRMS patients (SRT-LTS, CLTR, and Total Delay, 10/36
SRT and 10/36 SRT Delay) depended on whether age dif-
ferences were taken into account. The difference between
RRMS and PPMS patients on the WLG was smaller when
age differences were not controlled for (contrast estimate 
2.1, p  0.066). Previous analyses had revealed that linear
adjustment for age might not be ideal for this task. In sepa-
rate univariate analyses for WLG, RRMS and PPMS patients
and SPMS and PPMS patients still differed after the intro-
duction of a quadratic term for age (F[2,228] 7.6, p 0.001;
PP vs RR: 4.5, p  0.001; PP vs SP: 4.9, p  0.001). In
pairwise comparisons by age category, RRMS patients in
their forties or fifties performed poorer than PPMS patients
of the same age (forties: T[30]  2.7, p  0.011; fifties:
T[23]  4.5, p  0.001) (see table E-3 on the Neurology Web
site). SPMS patients in their fifties performed more poorly
than PPMS patients of the same age (T[36]  5.3, p  0.001).
When EDSS or disease duration replaced age as a co-
variate in the overall analyses, the results remained
largely unchanged. After controlling for EDSS, however,
RRMS and PPMS patients no longer differed on PASAT
(p  0.066 for PASAT_3; p  0.269 for PASAT_2) and
SDMT (p  0.320). The differences between RRMS and
SPMS patients on the PASAT and SDMT also decreased
(p  0.550 for PASAT_3; p  0.725 for PASAT_2; p 
0.044 for SDMT).
Discussion. We found that all MS groups have
cognitive deficits. Deficits were generally most se-
vere in SPMS patients, followed by PPMS patients
and then RRMS patients who differed from control
subjects in three of the five tasks of the BRB-N. We
also found that there is heterogeneity in the type of
cognitive disabilities demonstrated by patients with
different MS phenotypes. RRMS patients performed
significantly better on the SDMT and the PASAT
than PPMS and SPMS patients. Like all other tasks
of the BRB-N, SDMT and PASAT require specific
WM operations, which in turn require central pro-
cessing speed.20 PASAT and SDMT, however, appear
to depend more strongly on processing speed than
the other tasks, considering that PASAT is exter-
nally paced, whereas in the instruction of SDMT, the
emphasis is on performing as many substitutions as
possible within a given time span. The observed
group differences possibly reflect that progressive
MS subtypes have more widespread white matter
disease (either lesions or diffuse pathology), result-
ing in loss of information-processing speed. Dif-
ferences with RRMS patients were observed after
controlling for age but largely disappeared after
controlling for EDSS, which suggests that disease
Table 4 Contrast estimates (CEs) for differences between multiple sclerosis subtypes after controlling for age and gender
Test RR vs SP 95% CI p d RR vs PP 95% CI p d PP vs SP 95% CI p d
SRT
LTS CE  3.6 7.8 0.68 0.099 0.28 CE  4.6 9.9 0.63 0.084 0.33 CE  1.1 3.8 5.8 0.667 0.07
CLTR CE  7.4 12.3 2.6 0.003 0.51 CE  5.7 11.7 0.33 0.064 0.36 CE  1.7 7.2 3.8 0.535 0.11
Total Delay CE  1.1 1.8 0.40 0.002 0.54 CE  0.5 1.4 0.30 0.427 0.24 CE  0.54 1.3 0.23 0.166 0.23
PASAT
PASAT_2 CE  4.7 9.3 0.03 0.049 0.37 CE  5.5 11.2 0.28 0.062 0.36 CE  0.8 4.5 6.0 0.767 0.05
PASAT_3 CE  5.5 10.5 0.58 0.029 0.42 CE  8.0 14.21.9 0.010 0.50 CE  2.5 3.1 8.1 0.379 0.14
SDMT CE  10.0 14.5 5.4 0.001 0.71 CE  8.1 13.72.4 0.005 0.57 CE  1.9 7.1 3.3 0.476 0.12
10/36 Spatial Recall
10/36 SRT CE  3.8 5.5 2.1 0.001 0.73 CE  1.1 3.2 1.0 0.293 0.22 CE  2.7 4.6 0.75 0.006 0.53
10/36 SRT Delay CE  1.2 2.0 0.4 0.003 0.49 CE  0.08 1.1 0.89 0.864 0.04 CE  1.1 2.0 0.21 0.015 0.46
WLG CE  0.2 2.4 2.0 0.830 0.04 CE  4.4 1.7 7.2 0.002 0.65 CE  4.7 7.2 2.2 0.001 0.63
RR  relapsing - remitting; SP  secondary progressive; PP  primary progressive; SRT  Selective Reminding Test; LTS  Long-Term Storage; CLTR 
Consistent Long-Term Retrieval; PASAT  Paced Auditory Serial Addition Task (PASAT_2  2 s/digit; PASAT_3  3 s/digit); SDMT  Symbol Digit Mo-
dalities Test; 10/36 Spatial Recall (10/36 SRT  Immediate Recall; 10/36 SRT Delay  Delayed Recall); WLG  Word List Generation.
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severity accounts for more variation in information-
processing speed than age.
On the tasks requiring higher-order WM pro-
cesses with less evident processing speed demands,
that is, the 10/36 SRT and WLG, the SPMS patients
had more problems than the PPMS patients. Pa-
tients with RRMS also performed more poorly on
WLG than PPMS patients. Relatively poor spatial
WM in SPMS and RRMS compared with PPMS is in
agreement with findings from other studies.3,7,13 De-
spite the fact that poor verbal fluency and poor
higher-order WM memory operations have been
shown in RRMS before,5,6,14 poor verbal fluency in
RRMS relative to PPMS contrasts earlier findings.12
Our result does appear to be robust, considering the
fact that it remained significant after controlling for
a curvilinear relationship with age. Still, introducing
factors such as age, EDSS, and disease duration as
covariates might not be ideal as these are essentially
inherent to the disease subtype. For the same rea-
son, matching groups on age would be problematic
for the population of this study. However, when we
did take this approach for verbal fluency, poorer per-
formance by RRMS compared with PPMS was con-
firmed for patients in their forties and fifties.
Biochemical changes in response to inflammation
might help explaining cognitive differences between
MS subtypes.21,22 For instance, enhancing inflamma-
tory lesion events on MRI are more frequent in
SPMS and RRMS relative to PPMS8-10 and have been
associated with blood–brain barrier disruption.9,23 It
might be hypothesized that blood–brain barrier dis-
ruption interferes with normal transport ratios of
neurotransmitter precursors across the blood–brain
barrier, leading to specific neurotransmitter imbal-
ances, or that the blood–brain barrier becomes more
permeable, resulting in an increase of toxins in the
brain. Such mechanisms may be associated specifi-
cally with poor performance on the WLG and the
10/36 SRT, considering the fact that the WM opera-
tions required by these tasks were shown to be very
sensitive to catecholaminergic modulation24-26 and
proinflammatory cytokines.27,28
Future studies aiming at elucidating the patho-
physiology of cognition in different forms of MS
should employ sensitive cognitive tests that strongly
demand (central or peripheral) processing speed and
few other cognitive operations and tasks that require
high-order WM operations without an explicit de-
mand for information-processing speed.
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